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For several years, stroke, thromboembolic events and oral anticoagulant (OAC) 
related major bleeding have been the most feared clinical events considered among 
atrial fibrillation (AF)[1]. Consequently, the most part of attention was drawn to 
optimization of OAC therapy to obtain a reduction of thromboembolic events keeping 
low the incidence of bleeding adverse events[1]. More recently, a lot of focus has 
been paid to other outcomes as hospitalization/rehospitalization[2], myocardial 
infarction[3] and death (both cardiovascular and all-cause death)[4]. The evidence 
that other outcomes, not directly related to AF physiopathology, increased the 
awareness and the need for new approaches, based on patient’s holistic evaluation 
and multidisciplinary intervention[5].  
 
In this issue of the International Journal of Cardiology, Weber and colleagues 
presented a study analysing temporal trends of non-valvular AF hospitalizations in 
Western Australia from 2000 to 2013[6]. Interestingly, the authors both investigated 
age- and sex-stratified trends in total number of hospitalizations, also understanding 
the relative weight of admissions specifically due to perform a catheter ablation 
procedure, then analysed the impact of incident AF hospitalization in order to 
establish the role of new AF cases in determining the temporal trends. This study 
provided several interesting results. First of all, the authors documented a significant 
increase in the rate of total hospitalizations, with an age- and sex-standardised rate 
increased by 3.0%/year. Secondly, this increase in the rate of hospitalizations, while 
remained significant for both men and women, was found to be more pronounced in 
men (3.4%) than in women (2.5%). Then, taking account of the age classes, while in 
all the age classes a significant increase was found, by the end of follow-up 
observation the greater increase in hospitalization rates was found for patients aged 
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85-94 years, then in those aged 75-84 years, both in the overall cohort that in men 
and women separately[6]. 
 
Moving onwards, the authors documented that the increasing use of catheter 
ablation for rhythm control in AF patients significantly contributed to the observed 
increased rate, indeed a 13.3% annual increase was found, from 9.4 to 119.4 per 
1000 AF hospitalizations from 2000 to 2013. When the authors considered only the 
incident AF-related admission they reported that, different than the overall rate, a 
significant decrease was found, with an annual 0.5% decline. This decline in 
hospitalization rate was consistent in women, while was not significant in men; 
conversely only small changes were observed in age-stratified analysis[6]. 
 
The results provided by the authors fell in the previously shown evidence, that rates 
of hospitalization for AF patients are constantly increasing throughout time. In a 
paper published in 2014, Patel and colleagues already showed how the rate of 
hospitalization in the US from 2000 to 2010 significantly increased (+14.4% relative 
increase)[2]. This increase was more evident in elderly patients (≥65 years). Very 
importantly, in the same study, the authors reported a contemporary increase in the 
costs associated to the hospitalizations (+24.0% relative increase), also they 
underlined how the length of stay and cost of hospitalization progressively increased 
according to the increasing thromboembolic risk[2]. Similar data were also already 
retrieved from previous decades and Europe[7,8] 
 
Also, the results of the study by Weber and colleagues extended the previous 
knowledge from the same area. Indeed, in a previous study investigating rates of AF 
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hospitalization from 1993 to 2007, in comparison with those related to heart failure 
and myocardial infarction[9]. A 7.9% of annual increase was found for AF 
hospitalization number, with an absolute increase of 155% in prevalence of AF 
hospitalizations, while prevalence of hospitalizations for myocardial infarctions 
showed a significantly lower increase, while those for heart failure decreased 
progressively[9]. In the accompanying editorial to this paper, already underlined how 
the constant increase in the hospitalization rates for AF was a major issue in terms of 
health-care associated costs and health-care providers. All the amount of evidence 
available clearly indicates that the increasing path is now substantially consistent 
across the last 30 years.  
 
In this context, the paper from Weber and colleagues add an important piece of 
information. Indeed, the documented increase in AF hospitalization rates contrasting 
with the evidence that the hospitalizations for incident AF (i.e. much likely new AF 
cases) decreased at the same time, points out that the repeating hospitalizations in 
patients with established AF is the main contributor to the burden of hospitalizations 
in AF. This highlights the need for a more effective clinical management of AF 
patients, in order to reduce the risk of hospitalization, beyond the sole stroke 
prevention. In the paper from Patel and colleagues was also noted that in the 
framework of increased hospitalizations also the prevalence of comorbid conditions 
increased together with a progressively increase in age of AF patients[2], leading to 
an increase in the clinical complexity of these patients, as also underlined by other 
cohorts[4]. 
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Recently the “Atrial Fibrillation Better Care” (ABC) pathway has been proposed to 
streamline the holistic management of patients with AF[5]. The ABC pathway 
[Figure] considers a multifaceted approach for AF clinical management, 
contemporary addressing the optimization of oral anticoagulant therapy to reduce 
stroke and thromboembolic risk (‘A’ for Avoid stroke), treating patients’ symptoms to 
improve quality of life (‘B’ for Better symptoms management) and managing 
optimally other comorbidities (‘C’ for Cardiovascular and other comorbidities) in order 
to control for other risk factors and concomitant conditions[5]. A retrospective 
analysis from the “Atrial Fibrillation Follow-Up Investigation of Rhythm Management 
(AFFIRM) trial, modelling a clinical management resembling the ABC pathway, found 
out how this approach was associated with a reduced risk of major bleeding, all-
cause death, cardiovascular death and, relevantly, first hospitalization, first 
cardiovascular hospitalization and repeated hospitalizations[10]. 
 
In summary, facing the constant increase in hospitalization rates for AF patients, 
paired with the increasing age, clinical complexity and health-care associated costs, 
new approaches that will lead to a change in the clinical management are needed. 
Further data are still needed to assess the best way to address the clinical 
complexity in AF and to establish the best pathway to convey a proper holistic 
management, with the final goal to improve patients’ quality of life and outcomes. 
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FIGURE LEGENDS 
 
Figure: The “Atrial Fibrillation Better Care” (ABC) Pathway 
Legend: NOAC= Non-vitamin K antagonist oral anticoagulant; OAC= Oral 
anticoagulant; TTR= Time in therapeutic range; VKA= Vitamin K antagonist. 
Reprinted by permission from Springer Nature Customer Service Centre GmbH: 
Springer Nature, Nature Reviews Cardiology, Lip GY, “The ABC pathway: an 
integrated approach to improve AF management”, Copyright 2017[5]. 
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